RNAi New Drug Startup Sirnaomics Raises $105 Million

This Data Is Locked!

This area is available only to Subscribers.

Sirnaomics, Inc., which focuses on the application of nucleic acid interference technology (RNAi) for new drug creation, has completed a series D round of financing... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?